Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.

Clinical trial NCT03225417 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT03225417

Sponsor

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 1, Phase 2

Study type

INTERVENTIONAL

Start date

2017-05-16

Primary completion

2024-01-11

Enrollment

142

View on ClinicalTrials.gov